FDA Inspection 1222441 — ALS Pharma Ltda

ALS Pharma Ltda — FEI 3009005003

The FDA completed an inspection of ALS Pharma Ltda on November 8, 2023 in Paulinia. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 8, 2023
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Paulinia (Brazil)

Citations

IDCFRDescription
180921 CFR 211.160(a)Following/documenting laboratory controls
360321 CFR 211.160(b)Scientifically sound laboratory controls
430421 CFR 211.68(b)Written record not kept of program and validation data